We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




bioMérieux Acquires Microbial Genotyping Technology

By Labmedica staff writers
Posted on 03 Oct 2006
bioMérieux (Marcy-l'Etoile, France), a company specializing in in vitro diagnostics, has acquired Bacterial Barcodes (BBCI, Athens, Georgia, USA). More...
The financial terms of the acquisition were not disclosed.

BBCI is a molecular biotechnology company that developed and markets DiversiLab, a system dedicated to the field of automated microbial genotyping, offering solutions to track hospital-acquired infections (HAI) and for environmental control for product safety.

The technology automates the previously cumbersome method of strain typing and allows for better genotypic characterization of bacteria, yeast, and fungi, which helps identify the source and stop the spread of further infection. DiversiLab complements the bioMérieux suite of solutions, and together they support clinical decisions that may ultimately reduce HAIs and support the prudent usage of antibiotics.

The DiversiLab system eliminates complex manual laboratory procedures for determining the source of infections and contamination. DiversiLab allows healthcare practitioners and quality control/assurance departments to conduct investigations up to 10 times faster than previous methods. The system consists of web-based software for detection and analysis, and quality-controlled DNA fingerprinting kits (or reagents).

The technology is focused on the rapid identification of outbreak and contamination source tracking and is applicable in the hygiene market for tracking antibiotic resistant microorganisms causing hospital-acquired infections and in industrial markets for food, agricultural, pharmaceutical, and environmental contamination testing. It is also useful for characterizing biothreat agents and identifying potential outbreaks in the biodefense market.

"We are excited about the opportunity to join the industry leader in the field of infectious disease diagnostics and infection control and we feel positive about the impact our solutions can have in both the healthcare and industrial markets,” said Mimi Healy, Ph.D., president and CEO, BBCI. "The DiversiLab system perfectly complements bioMerieux's technology portfolio, which will help discriminate and track the spread and source of bacterial infections and contamination more quickly, more accurately, and more cost-effectively than other systems on the market today.”



Related Links:
bioMérieux
Bacterial Barcodes

Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
NEW PRODUCT : SILICONE WASHING MACHINE TRAY COVER WITH VICOLAB SILICONE NET VICOLAB®
REGISTRED 682.9
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.